Plain-English translation of NCT06397339 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Alzheimer Disease research guide โThis study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This study is testing a training program called INTACT that teaches primary care doctors how to better recognize, diagnose, and care for patients with mild memory problems and dementia. The program includes educational training for doctors, quarterly webinars about important topics like dementia and driving, and new clinic workflows to help doctors evaluate and manage patients with memory concerns. The goal is to improve how well American Indian and Alaska Native patients are identified and cared for when they develop memory loss.
Memory loss and dementia often go undetected or are managed poorly in primary care clinics, especially for American Indian and Alaska Native communities. This trial exists to see whether training doctors and updating clinic processes can help catch these conditions earlier and provide better care and support to patients and their families.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If your clinic is selected, you would complete a baseline survey and interview about your clinic and patient population. Your clinic would then be randomly assigned to either receive the INTACT training right away or join a wait-list to receive it after one year. Throughout the year, participating doctors would attend training sessions and quarterly webinars on topics like dementia care and caregiver support. Your clinic would also implement a new workflow for evaluating patients with memory concerns. At the end of one year, researchers will review medical records and survey responses to see if the training improved how doctors detect and manage memory loss.
AI-generated summary from trial data ยท Jun 16, 2026 ยท Not medical advice
United States
Sponsor
Washington State University
Collaborators
University of Washington, University of Miami
Enrollment target
~28 participants
Started
October 2022
Primary completion
April 2026
This trial's estimated completion date has passed โ the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Patrik Johansson, MD, MPH
Washington State University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.